MYRIAD GENETICS, INC. Contract Liability (Deferred Revenue)
MYRIAD GENETICS, INC. (MYGN) had Contract Liability (Deferred Revenue) of $500.00 thousand as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2024-02-28
- 2023-12-31: Contract with Customer, Liability, Current $500.00K.
- 2022-12-31: Contract with Customer, Liability, Current $600.00K.
- 2022-09-30: Contract with Customer, Liability, Current $200.00K.
- 2022-06-30: Contract with Customer, Liability, Current $300.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2023-12-31 | $500.00K 10-K · filed 2024-02-28 |
| 2022-12-31 | $600.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $200.00K 10-Q · filed 2022-11-02 |
| 2022-06-30 | $300.00K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $700.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $5.20M 10-K · filed 2024-02-28 |
| 2021-09-30 | $11.50M 10-Q · filed 2022-11-02 |
| 2021-06-30 | $22.60M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $31.10M 10-Q · filed 2022-05-06 |
| 2020-12-31 | $32.70M 10-K · filed 2024-02-28 |
| 2020-09-30 | $32.30M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $32.80M 10-K · filed 2023-03-01 |
| 2020-03-31 | $3.80M 10-Q · filed 2021-05-05 |
| 2019-12-31 | $3.60M 10-Q · filed 2021-11-04 |
| 2019-09-30 | $2.10M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $2.20M 10-K · filed 2023-03-01 |
| 2019-03-31 | $2.30M 10-Q · filed 2020-05-06 |
| 2018-12-31 | $2.40M 10-Q · filed 2020-02-07 |
| 2018-09-30 | $2.50M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $2.60M 10-K · filed 2022-02-25 |
| 2018-03-31 | $2.60M 10-Q · filed 2019-05-08 |
| 2017-12-31 | $3.40M 10-Q · filed 2019-02-06 |
| 2017-09-30 | $2.90M 10-Q · filed 2018-11-07 |
| 2017-06-30 | $2.60M 10-K · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |